Abrdn Life Sciences Investors Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Dan Omstead
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 23.3yrs |
| CEO ownership | 0.7% |
| Management average tenure | no data |
| Board average tenure | 18.3yrs |
Recent management updates
Recent updates
HQL: Hold Your Investments In This Healthcare CEF For Strong, Steady Yield
Sep 27HQL: 13% Discount Creates An Opportunity
Jun 29Tekla Life Sciences raises dividend by 6.5% to $0.33
Feb 15Tekla Life Sciences declines quarterly dividend by -11.4% to $0.31/share
Nov 16Tekla Life Sciences Investors: 10% Yield And Trading 10.5% Below NAV
Oct 23HQL: A Biotechnology Equity CEF With No Leverage
Jul 12HQL: Buy For The Yield, If You Can Stomach The Depreciation
Apr 27Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend
Feb 11Tekla Life Sciences Investors Rides Biotechnology Wave, Offers Growth With Steady Income
Sep 22Evaluating Closed-End Funds: HQL Is Another Fine Pick In A Hot Sector
Jun 29Tekla Life Sciences Investors: 8% Yield, 7% Discount
Jan 09Tekla Life Sciences declares $0.02 special dividend
Dec 21Tekla Life Sciences declares $0.40 dividend
Nov 16CEO
Dan Omstead (70 yo)
23.3yrs
Tenure
Dr. Daniel R. Omstead serves as Director at HotSpot Therapeutics, Inc. since April 2021. Dr. Omstead serves as the President since 2001, Chief Executive Officer, Chief Financial Officer, Manager, Trustee,...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Principal Executive Officer | 21.3yrs | no data | 0.72% $ 2.6m | |
| Trustee | 13.3yrs | US$26.50k | no data | |
| Chairman | 24.3yrs | US$34.50k | no data | |
| Independent Trustee | 32.3yrs | US$23.50k | no data | |
| Trustee | 14.3yrs | US$30.75k | no data | |
| Independent Trustee | 18.3yrs | US$28.00k | no data | |
| Trustee | 17.3yrs | US$24.00k | no data | |
| Trustee | no data | no data | no data |
18.3yrs
Average Tenure
74.5yo
Average Age
Experienced Board: HQL's board of directors are seasoned and experienced ( 18.3 years average tenure).